Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price was down 3.8% during trading on Thursday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The stock’s 50-day moving average is C$0.26 and its 200 day moving average is C$0.26. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The company has a market cap of C$52.28 million and a PE ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- The 3 Best Blue-Chip Stocks to Buy Now
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 11/18 – 11/22
- Dividend Capture Strategy: What You Need to Know
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
